Oncogenic human papillomavirus 16E7 modulates SUMOylation of FoxM1b

International Journal of Biochemistry and Cell Biology

Volumn 58, Issue , 2015, Pages 28-36

  Jaiswal, Neha ^a   John, Rince ^a   Chand, Vaibhav ^a   Nag, Alo ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Cervical cancer; Degradation; FoxM1b; HPV16 E7; SUMOylation

Indexed keywords

FORKHEAD BOX M1B PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN E7; UNCLASSIFIED DRUG; FOXM1 PROTEIN, HUMAN; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN-CONJUGATING ENZYME UBC9;

ARTICLE; CARCINOGENESIS; CELL FRACTIONATION; CONJUGATION; CONTROLLED STUDY; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUMOYLATION; U2OS CELL LINE; UPREGULATION; CELL LINE; GENETICS; IMMUNOPRECIPITATION; METABOLISM; TUMOR CELL LINE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; PAPILLOMAVIRUS E7 PROTEINS; SUMOYLATION; UBIQUITIN-CONJUGATING ENZYMES; UTERINE CERVICAL NEOPLASMS;

EID: 84911885372     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.11.002     Document Type: Article

References (45)

1. Ahn J-H, Xu Y, Jang W-J, Matunis MJ, Hayward GS. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J Virol 2001;75:3859-72.
2. Alvarez-Fernández M, Medema RH. Novel functions of FoxM1: from molecular mechanisms to cancer therapy. Front Oncol 2013;3., http://dx.doi.org/10.3389/fonc.2013.00030.
3. Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, et al. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 2011;112:2296-306.
4. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004;428:431-7.
5. Chan D, Yu S, Chiu P, Yao K, Liu V, Cheung A, et al. Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol 2008;215:245-52.
6. Chand V, John R, Jaiswal N, Johar S, Nag A. High risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation. Carcinogenesis 2014;35:1830-9.
7. Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol 2010;11:861-71.
8. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007;8:947-56.
9. Gill G. Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr Opin Genet Dev 2003;13:108-13.
10. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev 2005;15:536-41.
11. Girard M, Goossens M. Sumoylation of the SOX10 transcription factor regulates its transcriptional activity. FEBS Lett 2006;580:1635-41.
12. Halasi M, Gartel AL. FOX(M1) news - it is cancer. Mol Cancer Ther 2013;12:245-54.
13. Heaton PR, Deyrieux AF, Bian X-L, Wilson VG. HPV E6 proteins target Ubc9, the SUMO conjugating enzyme. Virus Res 2011;158:199-208.
14. Jaiswal N, Chakraborty S, Nag A. Biology of FOXM1 and its emerging role in cancer therapy. J Proteins Proteomics 2014;5:1-24.
15. Kalin TV, Wang IC, Ackerson TJ, Major ML, Detrisac CJ, Kalinichenko VV, et al. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 2006;66:1712-20.
16. Khongkow P, Karunarathna U, Khongkow M, Gong C, Gomes A, Yagüe E, et al. FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance. Oncogene 2013., http://dx.doi.org/10.1038/onc.2013.1457.
17. Kim I-M, Ackerson T, Ramakrishna S, Tretiakova M, Wang I-C, Kalin TV, et al. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006;66:2153-61.
18. Koo C-Y, Muir KW, Lam EW-F. FOXM1: from cancer initiation to progression and treatment. Biochim Biophys Acta 2012;1819:28-37.
19. Laoukili J, Alvarez-Fernandez M, Stahl M, Medema RH. FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner. Cell Cycle 2008;7:2720-6.
20. Laoukili J, Kooistra MR, Brás A, Kauw J, Kerkhoven RM, Morrison A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 2005;7:126-36.
21. Laoukili J, Stahl M, Medema RH. FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 2007;1775:92-102.
22. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, et al. a p53-induced ubiquitinprotein ligase, promotes p53 degradation. Cell 2003;112:779-91.
23. Lüscher-Firzlaff JM, Westendorf JM, Zwicker J, Burkhardt H, Henriksson M, Müller R, et al. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene 1999;18:5620-30.
24. Ma RY, Tong TH, Cheung AM, Tsang AC, Leung WY, Yao K-M. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 2005;118:795-806.
25. Major ML, Lepe R, Costa RH. Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol Cell Biol 2004;24:2649-61.
26. Mo Y-Y, Yu Y, Theodosiou E, Ee PR, Beck WT. A role for Ubc9 in tumorigenesis. Oncogene 2005;24:2677-83.
27. Myatt S, Kongsema M, Man CW, Kelly D, Gomes A, Khongkow P, et al. SUMOylation inhibits FOXM1 activity and delays mitotic transition. Oncogene 2013., http://dx.doi.org/10.1038/onc.2013.546.
28. Nag A, Datta A, Yoo K, Bhattacharyya D, Chakrabortty A, Wang X, et al. DDB2 induces nuclear accumulation of the hepatitis B virus X protein independently of binding to DDB1. J Virol 2001;75:10383-92.
29. Park HJ, Costa RH, Lau LF, Tyner AL, Raychaudhuri P. Anaphase-promoting complex/cyclosome-CDH1-mediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase. Mol Cell Biol 2008;28:5162-71.
30. Park HJ, Gusarova G, Wang Z, Carr JR, Li J, Kim KH, et al. Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med 2011;3:21-34.
31. Raychaudhuri P, Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res 2011;71:4329-33.
32. Schimmel J, Eifler K, Sigurosson JO, Cuijpers SA, Hendriks IA, Verlaan-de Vries M, et al. Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol Cell 2014;53:1053-66.
33. Tan Y, Raychaudhuri P, Costa RH. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol 2007;27:1007-16.
34. Varadaraj A, Mattoscio D, Chiocca S. SUMO Ubc9 enzyme as a viral target. IUBMB Life 2014;66:27-33.
35. Wang I-C, Chen Y-J, Hughes D, Petrovic V, Major ML, Park HJ, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 2005;25:10875-94.
36. Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev 2010;36:151-6.
37. Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. J Biol Chem 2007;388:1257-74.
38. Wilson VG. Sumoylation at the host-pathogen interface. Biomolecules 2012;2:203-27.
39. Wimmer P, Schreiner S, Dobner T. Human pathogens and the host cell SUMOylation system. J Virol 2012;86:642-54.
40. Wonsey DR, Follettie MT. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 2005;65:5181-9.
41. Yang C, Chen H, Tan G, Gao W, Cheng L, Jiang X, et al. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Cancer Lett 2013;340:104-12.
42. Ye H, Holterman AX, Yoo KW, Franks RR, Costa RH. Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase. Mol Cell Biol 1999;19:8570-80.
43. Yokota K, Shibata H, Kurihara I, Kobayashi S, Suda N, Murai-Takeda A, et al. Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. J Biol Chem 2007;282:1998-2010.
44. Zeng J, Wang L, Li Q, Li W, Björkholm M, Jia J, et al. FoxM1 is upregulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kip1. J Pathol 2009;218:419-27.
45. Zhang Y, Zhang N, Dai B, Liu M, Sawaya R, Xie K, et al. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 2008;68:8733-42.